Kerklaan P R, Bouter S, van Elburg P A, Mohn G R
Mutat Res. 1985 Jan-Feb;148(1-2):1-12. doi: 10.1016/0027-5107(85)90202-7.
The DNA-repair host-mediated assay was further calibrated by determining the genotoxic activities of 4 methylating carcinogens, namely, dimethylnitrosamine (DMNA), 1,2-dimethylhydrazine (SDMH), methyl nitrosourea (MNU) and methyl methanesulphonate (MMS) in various organs of treated mice. The ranking of the animal-mediated genotoxic activities of the compounds was compared with that obtained in DNA repair assays performed in vitro. The differential survival of strain E. coli K-12/343/113 and of its DNA-repair-deficient derivatives recA, polA and uvrB/recA, served as a measure of genotoxic potency. In the in vitro assays and at equimolar exposure concentrations, MMS and MNU are the most active chemicals, followed by DMNA, which shows a slight genotoxic effect only in the presence of mouse liver homogenate; SDMH has no activity under these conditions. In the host-mediated assays, the order of genotoxic potency of the compounds was quite different: those carcinogens which require mammalian metabolic activation, namely, DMNA and SDMH, show strong effects in liver and blood, a lesser effect in the lungs and kidneys and the least effect in the spleen. The activity of MNU, a directly acting compound, is similar in all organs investigated, but it is clearly lower than that of DMNA and SDMH. MMS, also a directly acting carcinogen, causes some (barely significant) effect at the highest dose tested. A similar order of potency was observed when the compounds were tested in intrasanguineous host-mediated assays with gene mutation as an endpoint. DMNA and SDMH induce comparable frequencies of L-valine-resistant mutants in E. coli K-12/343/113 recovered from liver and spleen of treated mice, the effect in the liver being the strongest. MNU is mutagenic only at a higher dose, while MMS shows no effect. The results are discussed with respect to the literature data on organ-specific DNA adduct formation induced by the compounds. It is concluded that qualitatively there is a good correlation between the degree of genotoxic activity found in the DNA repair host-mediated assay and DNA adduct formation in the animal's own cells. This is exemplified by the finding that the relative order of genotoxic activity of the 4 methylating agents in bacteria recovered from various organs (DMNA approximately equal to SDMH greater than MNU greater than MMS) is reflected by the same order of magnitude in DNA alkylation in corresponding mammalian organs. Quantitatively, the indirectly acting agents DMNA and SDMH seem to induce fewer genotoxic effects in bacteria present in the liver than would be expected on the basis of DNA-adduct formation data.
通过测定4种甲基化致癌物,即二甲基亚硝胺(DMNA)、1,2 - 二甲基肼(SDMH)、甲基亚硝基脲(MNU)和甲基磺酸甲酯(MMS)在经处理小鼠各器官中的遗传毒性活性,对DNA修复宿主介导试验进行了进一步校准。将这些化合物在动物介导的遗传毒性活性排名与在体外进行的DNA修复试验中获得的排名进行比较。大肠杆菌K - 12/343/113及其DNA修复缺陷衍生物recA、polA和uvrB/recA的差异存活率,作为遗传毒性强度的一种度量。在体外试验中,在等摩尔暴露浓度下,MMS和MNU是活性最强的化学物质,其次是DMNA,它仅在存在小鼠肝脏匀浆时显示出轻微的遗传毒性作用;在这些条件下SDMH无活性。在宿主介导试验中,这些化合物的遗传毒性强度顺序有很大不同:那些需要哺乳动物代谢激活的致癌物,即DMNA和SDMH,在肝脏和血液中显示出强烈作用,在肺和肾脏中作用较小,在脾脏中作用最小。MNU是一种直接作用的化合物,在所有研究的器官中活性相似,但明显低于DMNA和SDMH。MMS也是一种直接作用的致癌物,在测试的最高剂量下引起一些(勉强显著的)作用。当以基因突变作为终点在血液内宿主介导试验中测试这些化合物时,观察到了类似的强度顺序。DMNA和SDMH在从经处理小鼠的肝脏和脾脏中回收的大肠杆菌K - 12/343/113中诱导出相当频率的L - 缬氨酸抗性突变体,在肝脏中的作用最强。MNU仅在较高剂量下具有致突变性,而MMS无作用。结合关于这些化合物诱导的器官特异性DNA加合物形成的文献数据对结果进行了讨论。得出的结论是,定性地说,在DNA修复宿主介导试验中发现的遗传毒性活性程度与动物自身细胞中的DNA加合物形成之间存在良好的相关性。这一点通过以下发现得到例证:从各器官回收的细菌中4种甲基化剂的遗传毒性活性相对顺序(DMNA约等于SDMH大于MNU大于MMS)在相应哺乳动物器官的DNA烷基化中以相同的量级顺序体现出来。定量地说,间接作用的试剂DMNA和SDMH在肝脏中的细菌中似乎诱导出比基于DNA加合物形成数据预期的更少的遗传毒性作用。